<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE us-patent-application SYSTEM "us-patent-application-v43-2012-12-04.dtd" [ ]><us-patent-application lang="EN" dtd-version="v4.3 2012-12-04" file="US20140004139A1-20140102.XML" status="PRODUCTION" id="us-patent-application" country="US" date-produced="20131218" date-publ="20140102"><us-bibliographic-data-application lang="EN" country="US"><publication-reference><document-id><country>US</country><doc-number>20140004139</doc-number><kind>A1</kind><date>20140102</date></document-id></publication-reference><application-reference appl-type="utility"><document-id><country>US</country><doc-number>14010668</doc-number><date>20130827</date></document-id></application-reference><us-application-series-code>14</us-application-series-code><classifications-ipcr><classification-ipcr><ipc-version-indicator><date>20060101</date></ipc-version-indicator><classification-level>A</classification-level><section>C</section><class>07</class><subclass>K</subclass><main-group>14</main-group><subgroup>32</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source></classification-ipcr></classifications-ipcr><classifications-cpc><main-cpc><classification-cpc><cpc-version-indicator><date>20130101</date></cpc-version-indicator><section>C</section><class>07</class><subclass>K</subclass><main-group>14</main-group><subgroup>32</subgroup><symbol-position>F</symbol-position><classification-value>I</classification-value><action-date><date>20140102</date></action-date><generating-office><country>US</country></generating-office><classification-status>B</classification-status><classification-data-source>H</classification-data-source><scheme-origination-code>C</scheme-origination-code></classification-cpc></main-cpc></classifications-cpc><classification-national><country>US</country><main-classification>4241901</main-classification><further-classification>435  792</further-classification></classification-national><invention-title id="d0e43">SEROLOGIC CORRELATES OF PROTECTION AGAINST BACILLIS ANTHRACIS INFECTION</invention-title><us-related-documents><continuation-in-part><relation><parent-doc><document-id><country>US</country><doc-number>13577878</doc-number><date>20120808</date></document-id><parent-status>PENDING</parent-status><parent-pct-document><document-id><country>WO</country><doc-number>PCT/US11/24317</doc-number><date>20110210</date></document-id></parent-pct-document></parent-doc><child-doc><document-id><country>US</country><doc-number>14010668</doc-number></document-id></child-doc></relation></continuation-in-part><us-provisional-application><document-id><country>US</country><doc-number>61333456</doc-number><date>20100511</date></document-id></us-provisional-application><us-provisional-application><document-id><country>US</country><doc-number>61303055</doc-number><date>20100210</date></document-id></us-provisional-application></us-related-documents><us-parties><us-applicants><us-applicant sequence="00" app-type="applicant" designation="us-only" applicant-authority-category="assignee"><addressbook><orgname>Centers for Disease Control and Prevention</orgname><address><city>Atlanta</city><state>GA</state><country>US</country></address></addressbook><residence><country>US</country></residence></us-applicant></us-applicants><inventors><inventor sequence="00" designation="us-only"><addressbook><last-name>Semenova</last-name><first-name>Vera A.</first-name><address><city>Lilburn</city><state>GA</state><country>US</country></address></addressbook></inventor><inventor sequence="01" designation="us-only"><addressbook><last-name>Quinn</last-name><first-name>Conrad P.</first-name><address><city>Lilburn</city><state>GA</state><country>US</country></address></addressbook></inventor><inventor sequence="02" designation="us-only"><addressbook><last-name>Pohl</last-name><first-name>Jan</first-name><address><city>Tucker</city><state>GA</state><country>US</country></address></addressbook></inventor><inventor sequence="03" designation="us-only"><addressbook><last-name>Svoboda</last-name><first-name>Pavel</first-name><address><city>Atlanta</city><state>GA</state><country>US</country></address></addressbook></inventor><inventor sequence="04" designation="us-only"><addressbook><last-name>Dalton</last-name><first-name>Shannon</first-name><address><city>Stone Mountain</city><state>GA</state><country>US</country></address></addressbook></inventor><inventor sequence="05" designation="us-only"><addressbook><last-name>Schiffer</last-name><first-name>Jarad M.</first-name><address><city>Atlanta</city><state>GA</state><country>US</country></address></addressbook></inventor></inventors></us-parties><assignees><assignee><addressbook><orgname>Centers for Disease Control and Prevention</orgname><role>02</role><address><city>Atlanta</city><state>GA</state><country>US</country></address></addressbook></assignee></assignees></us-bibliographic-data-application><abstract id="abstract"><p id="p-0001" num="0000">Regions of <i>B. anthracis </i>protective antigen are provided representing sequences recognized by antibodies in subjects that have vaccine induced lethal toxin neutralizing anti-PA IgG responses. The recognition of these PA regions enhances the utility of anti-PA IgG reactivity as an immune correlate of protection against anthrax in a subject and increases predictive probability of survival. Also provided are vaccines that include at least one of these PA regions that when administered to a subject improve the predictive value of vaccine induced anti-PA IgG and TNA responses as immune correlates of protection against inhalation anthrax.</p></abstract></us-patent-application>